Cargando…

Pathophysiology of depression and mechanisms of treatment

Major depression is a serious disorder of enormous sociological and clinical relevance. The discovery of antidepressant drugs in the 1950s led to the first biochemical hypothesis of depression, which suggested that an impairment in central monoaminergic function was the major lesion underlying the d...

Descripción completa

Detalles Bibliográficos
Autor principal: Brigitta, Bondy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181668/
https://www.ncbi.nlm.nih.gov/pubmed/22033824
_version_ 1782212785444225024
author Brigitta, Bondy
author_facet Brigitta, Bondy
author_sort Brigitta, Bondy
collection PubMed
description Major depression is a serious disorder of enormous sociological and clinical relevance. The discovery of antidepressant drugs in the 1950s led to the first biochemical hypothesis of depression, which suggested that an impairment in central monoaminergic function was the major lesion underlying the disorder. Basic research in all fields of neuroscience (including genetics) and the discovery of new antidepressant drugs have revolutionized our understanding of the mechanisms underlying depression and drug action. There is no doubt that the monoaminergic system is one of the cornerstones of these mechanisms, but multiple interactions with other brain systems and the regulation of central nervous system function must also be taken into account In spite of all the progress achieved so far, we must be aware that many open questions remain to be resolved in the future.
format Online
Article
Text
id pubmed-3181668
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31816682011-10-27 Pathophysiology of depression and mechanisms of treatment Brigitta, Bondy Dialogues Clin Neurosci State of the Art Major depression is a serious disorder of enormous sociological and clinical relevance. The discovery of antidepressant drugs in the 1950s led to the first biochemical hypothesis of depression, which suggested that an impairment in central monoaminergic function was the major lesion underlying the disorder. Basic research in all fields of neuroscience (including genetics) and the discovery of new antidepressant drugs have revolutionized our understanding of the mechanisms underlying depression and drug action. There is no doubt that the monoaminergic system is one of the cornerstones of these mechanisms, but multiple interactions with other brain systems and the regulation of central nervous system function must also be taken into account In spite of all the progress achieved so far, we must be aware that many open questions remain to be resolved in the future. Les Laboratoires Servier 2002-03 /pmc/articles/PMC3181668/ /pubmed/22033824 Text en Copyright: © 2002 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle State of the Art
Brigitta, Bondy
Pathophysiology of depression and mechanisms of treatment
title Pathophysiology of depression and mechanisms of treatment
title_full Pathophysiology of depression and mechanisms of treatment
title_fullStr Pathophysiology of depression and mechanisms of treatment
title_full_unstemmed Pathophysiology of depression and mechanisms of treatment
title_short Pathophysiology of depression and mechanisms of treatment
title_sort pathophysiology of depression and mechanisms of treatment
topic State of the Art
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181668/
https://www.ncbi.nlm.nih.gov/pubmed/22033824
work_keys_str_mv AT brigittabondy pathophysiologyofdepressionandmechanismsoftreatment